ArticleThe Journal of infectious diseases2014
Reply to Karch et al.
Hiroyu Hatano, Peter Bacchetti, Priscilla Y Hsue, Steven G Deeks
Abstract readLetterComment
In one paragraphArticle in The Journal of infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
4 authors.
Hiroyu Hatano
Peter Bacchetti
Priscilla Y Hsue
Steven G Deeks
Funding
UCSF CLINICAL AND TRANSLATIONAL SCIENCE INSTITUTEUL1RR024131 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JOHNSTON, S. CLAIBORNE · 2006 to 2011
$111.2MUnsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4MVirology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6MEngaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0MUjima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4MUCSD Department of Medicine HIV/AIDS Clinical Trials UnitUM1AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TIMOTHY J. WILKIN · 2012 to 2026
$50.4MUsing NK Cells to eliminate the latent HIV reservoirU19AI096113 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LUCIW, PAUL · 2011 to 2015
$39.5MViral reservoirs and sanctuaries in HAART - treated patients: role and mechanismsU19AI096109 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVENSON, MARIO · 2011 to 2015
$29.5MTransmission ProbabilityP01AI074621 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2008 to 2012
$23.1MUCSD Department of Medicine HIV/AIDS Clinical Trials UnitU01AI069432 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 2007 to 2011
$19.3MInflammation, Viral Replication, and Atherosclerosis in Treated HIV InfectionR01HL095130 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSUE, PRISCILLA Y. · 2008 to 2012
$5.1MBiomathematical analysis of viral dynamics/evolutionR01AI047745 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI RICHMAN, DOUGLAS D · 2001 to 2011
$3.2MNCATS NIH HHS UL1 TR000004NCRR NIH HHS UL1 RR024131NHLBI NIH HHS R01 HL095130NIAID NIH HHS AI047745NIAID NIH HHS AI080193NIAID NIH HHS AI69432NIAID NIH HHS AI74621NIAID NIH HHS K24 AI069994NIAID NIH HHS P01 AI074621NIAID NIH HHS P01 AI080193NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI047745NIAID NIH HHS R01 AI087145NIAID NIH HHS R21 AI047745NIAID NIH HHS R24 AI067039NIAID NIH HHS R56 AI047745NIAID NIH HHS U01 AI069432NIAID NIH HHS U19 AI096109NIAID NIH HHS U19 AI0961090NIAID NIH HHS U19 AI096113NIAID NIH HHS UM1 AI069432NIMH NIH HHS P30 MH062246NIMH NIH HHS P30 MH62246
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
FemaleFibrin Fibrinogen Degradation ProductsHIV-1HIV InfectionsHIV Integrase InhibitorsHIV Long Terminal RepeatHumansMalePyrrolidinonesFibrin Fibrinogen Degradation ProductsHIV Integrase InhibitorsPyrrolidinones
Identifiers
PMID24421253
PMCPMC4161999
What OpenQuestion holds
Textmetadata
Read underepoch 390